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Abstract 
Purpose: To evaluate the reliability of analysis of only 0-1min clips and 1-4min clips versus the entire 
clips in performing contrast-enhanced ultrasonography (CEUS) of focal liver lesions (FLLs). 
Methods: Contrast-enhanced ultrasonography (CEUS) examinations of 43 single FLLs were performed. 
All clips were analyzed in three ways, the entire clips, 0-1 min clips and 1-4 min clips, benign or 
malignant diagnosis and pathological diagnosis of each FLL were concluded by the three ways 
subsequently.  
Results: The results of correct diagnosis were assessed using Chi-square test. There was no 
difference with regard to benign or malignant diagnosis, between 0-1min clips and the entire clips, or 
between 1-4 min clips  and the entire clips (p = 0.243 and p = 0.747, respectively). Moreover, no 
significant differences in pathological diagnosis existed between 0-1min clips and the entire clips, and 1-
4min clips versus entire clips (p=0.808 and p = 0.808, respectively). No significant differences existed 
among CEUS entire clip, 0-1min clip and 1-4min clip in identifying FLLs, and based on which the 
diagnosis of two different FLLs during CEUS with only one injection of contrast agent can be available. 
Conclusion: Only 0-1min clips or 1-4 min clips can be used to instead of the entre clip in performing 
CEUS of FLLs. 
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Contrast-enhanced ultrasonography (CEUS) is a 
widespread imaging procedure for investigating 
the liver parenchyma. The injection of ultrasound 
contrast agents (USCA) and the use of 
specialized imaging techniques now allow to 
display tissue macro and micro-vascularization 
similarly to what is seen with contrast- enhanced 
computed tomography (CECT) or magnetic 
resonance imaging (CEMRI) [1]. Ultrasound 
contrast agents present a pure intravascular 
distribution and do not leak in the interstitial 
space but persist in the sinusoids and portal 
vessels without the evidence of any equilibrium 
phase [2]. The peculiar hepatic vascularization 
allows defining different vascular phases. The 
arterial phase starts from 10-20 s after the 
injection of MBs, lasts for approximately 10 - 15 s 
and provides information on the degree and 
pattern of vascularity. The portal phase then lasts 
for 2 min after the start of injection, whereas the 
subsequent late phase lasts for up to 4–6 min 
after injection, until microbubble clearance from 
the liver parenchyma. Both portal phase and late 
phase provide information about the wash-out of 
focal liver lesions (FLLs) compared to the 
surrounding parenchyma (the term wash-out 
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describes a transition from some enhancement 
of a lesion, either iso- or hyper enhancement, to 
a clear hypoenhancement) [3]. 
 
During the last few years, many studies have 
investigated the CEUS patterns of FLLs, 
establishing their typical behavior in the arterial, 
portal and venous phases [3]. Several papers 
have described the general capabilities of CEUS 
in improving focal liver lesion characterization [2]. 
CEUS is now a reliable imaging tool with well-
established applications in the characterization of 
liver lesions with the possibility of prolonged liver 
ultrasound examination, and is easily performed.  
 
One limitation of CEUS in comparison to 
multiphase CT and MR imaging is the fact that 
only one liver lesion can be examined at a time 
as the transducer has to be kept still during the 
examination, and further contrast injections are 
necessary to characterize additional liver tumors.  
To date, a single clip over 180 s is required to 
analyze all phases (arterial, venous and late 
phases) of contrast behavior. The process lasts a 
long time and thus has to be performed off-line in 
“back-office” work and the analysis of entire 
video clips is very time-consuming and 
demanding in terms of technical resources, thus 
limiting potential applications in routine clinical 
use especially in assessing two different FLLs. In 
the attempt to simplify the process and to 
reduces acquisition time associated with CEUS, 
the entire clips of CEUS were divided into two 
clips, 0-1min clips and 1-4min clips, then the ratio 
of correct diagnosis and the statistical differences 
were analyzed in this study to evaluate the 
reliability of analysis of only 0-1min clips and 1-




Patients and lesions 
 
All patients with single FLL who had undergone 
pathological examination originating from 
operation or biopsy and previously assessed with 
CEUS were considered eligible for this study. 
Patients with any of the following conditions were 
excluded: 
 
1. Previous adverse reactions to Sonovue 
(Bracco Imaging, Milan, Italy), 
2. Severe pulmonary hypertension; 
3. Pregnancy or breastfeeding conditions;  
4. Portal vein thrombus and postcava thrombus;  
5. Evidence of critical illness or medical 
instability; 
6. History of operation and minimally invasive 
therapy; 
7. Poor image quality of the FLL. 
 
Written informed consent was obtained from all 
patients before the examination, and the study 
was approved by the Institutional Review Board 
and Ethics Committee of Tongji Hospital, Tongji 
Medical College, Huazhong University of Science 
and Technology (no. TJ-C20121213). All CEUS 
studies were performed for clinical purposes and 





Vivid E9 (GE, America) equipped with a 3.5 MHz 
harmonic-imaging transducer was used for 
CEUS and clip recording. Initially, a B-mode scan 
was performed to identify the best approach to 
the lesion. This consisted in choosing a scan in 
which the lesion was located in the mid-near field 
and remained visible during respiratory 
movements. The choice of the mid-near field was 
made based on previous findings, showing that 
this region provides the highest reproducibility. 
Thereafter, a bolus of 2.4 ml of Sonovue (Bracco 
Imaging, Milan, Italy), a second generation 
contrast agent composed of microbubbles of 
sulphur hexafluoride, was injected intravenously 
in an antecubital vein with a 22-gauge 
angiocatheter, extension tubing and a three-way 
stopcock., followed by 5 ml flush of NaCl (0.9 %) 
in bolus. Zero time was recorded at the 
completion of Sonovue flush. A continuous video 
clip of CEUS was acquired (duration 3-4min) 
following contrast injection. All investigations 
were performed in the same standardized way by 
the same expert operator, with 10 years of 




The CEUS clips were analyzed in 3 ways: (a) the 
entire clips, (b) 0-1min clips, referred to here as 
artery and earlier portal phase methodology, (c) 
1-4min clips, referred to here as later portal 
phase and late phase methodology. The CEUS 
clips were divided by an external operator, 
following a training period. 
 
All images, including grayscale, color Doppler 
ultrasound images and CEUS clips were 
evaluated in DICOM format with computer 
workstation. Two blinded radiologist readers, 
both with 5 years of experience in CEUS, 
independently reviewed all the ultrasound 
examinations. Both readers were blinded to 
clinical features, laboratory examinations and 
other imaging findings. Then readers were asked 
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to provide the most likely diagnosis (i.e., benign 
or malignant diagnosis, pathological diagnosis or 
indeterminate) for each focal liver lesion 




Collected data were entered into a common 
spreadsheet and summary statistics were 
calculated. Categorical variables were assessed 
using the chi-square test. All the data were 
analyzed with SPSS 18.0. The results are 
expressed as mean ± standard deviation (SD) for 





Contrast Tuned Imaging software was utilized for 
contrast detection (Figure 1); dynamic range set 
at 7, mechanical index at 0.03, acoustic power at 
40 kPa, frame rate at 15 Hz, sectorial gains at 
zero. Visualization was always kept in dual mode 
display. 
 
In our present investigation, 43 patients including 
29 men and 14 women, who ranged in age from 
21 to 78 years, with satisfactory image quality 
were analyzed. The differences in the clinical 
characteristics are reported in Table 1. The study 
comprised 43 lesions (16 hepatocellular 
carcinomas, 2 intrahepatic cholangiocarcinomas, 
2 regenerative nodules, 7 liver metastases 
carcinomas, 4 focal nodular hyperplasias, 
6hemangiomas, 1 hepatocellular adenoma, 3 
inflammatory pseudotumors, 1 liver abscess, 1 
hematoma). The final diagnosis was established 
using operation and biopsy. The median 
diameter of the lesions was 4.2 cm (0.8–14.4 
cm). 
 
The results of the entire clips, 0-1min clips and 1-
4min clips concerning benign and malignant 
diagnosis as well as pathological diagnosis are 
shown in Tables 2 and 3. There were no 
differences with regard to benign or malignant 
diagnosis between 0-1min clips versus the entire 
clips as well as 1-4min clips versus the entire 
clips (p = 0.243 and p = 0.747, respectively) 
(Table 4). Moreover, no significant differences in 
pathological diagnosis existed between 0-1min 
clips versus the entire clips and 1-4min clips 
versus the entire clips (p = 0.808 and p = 0.808, 




So far, many studies have investigated the 
CEUS patterns for FLLs examination, 
establishing their typical behavior in the arterial, 
portal and venous phases [3]. Malignancies 
typically show low echo-signal intensity at late 
phase [5,6], and the contrast pattern that 
characterizes benign FLLs is the absence of 
wash-out in the portal-venous and late phases 
[2]. Besides, benign and malignant FLLs may 
occur in cirrhosis and fatty liver [7,8]. 
 
 
Figure 1: Contrast tuned imaging. On the left of the screen, the hypoechoic focal liver lesion-hepatocellular 
carcinoma (arrow) is displayed in B-mode modality, while on the right the lesion (arrow) is displayed in Contrast 
Tuned Imaging (CnTI) technology. Thus the Real-time CEUS and the gray-scale image can be performed at the 
same time 
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Entire clip 0-1min Clip 1-4min Clip 
Diagnosis Pathology Diagnosis Pathology Diagnosis Pathology 
3.1 HCC malignant HCC indeterminate indeterminate malignant HCC 
5.2 HCC malignant indeterminate indeterminate indeterminate indeterminate indeterminate 
2.8 HCC malignant HCC malignant HCC malignant HCC 
4.5 HCC indeterminate indeterminate malignant HCC benign indeterminate 
5.2 HCC malignant HCC malignant HCC malignant HCC 
4 HCC malignant HCC malignant HCC malignant HCC 
3.1 HCC malignant HCC malignant HCC indeterminate indeterminate 
0.8 HCC malignant HCC malignant HCC malignant HCC 
1.3 HCC malignant HCC malignant HCC malignant HCC 
2.6 HCC malignant HCC malignant HCC malignant HCC 
7.2 HCC malignant HCC malignant HCC malignant HCC 
5.6 HCC malignant HCC malignant HCC malignant HCC 
1.5 HCC malignant HCC malignant HCC malignant HCC 
6.4 HCC malignant HCC malignant HCC malignant HCC 
3.2 HCC malignant HCC malignant HCC malignant HCC 
6.7 HCC malignant HCC malignant HCC malignant HCC 
4.2 ICC malignant ICC malignant ICC malignant HCC 
2.7 ICC malignant HCC malignant HCC malignant HCC 
3.3 RN malignant HCC malignant HCC malignant HCC 
3.9 RN malignant HCC malignant HCC benign RN 
3 adenoma malignant HCC malignant HCC benign indeterminate 
4.7 IP indeterminate indeterminate indeterminate indeterminate indeterminate indeterminate 
2.1 IP malignant HCC malignant HCC indeterminate indeterminate 
2.5 IP benign indeterminate benign indeterminate benign indeterminate 
7.1 abscess benign abscess benign abscess benign abscess 
14.4 hematoma benign hematoma benign hematoma benign hematoma 
4.5 FNH benign FNH benign FNH benign FNH 
2.6 FNH benign FNH benign FNH benign FNH 
7.7 FNH benign FNH benign FNH benign FNH 
5 FNH benign indeterminate malignant HCC benign indeterminate 
3.4 
Hemangiom
a benign hemangioma Benign hemangioma benign hemangioma 
6.8 
Hemangiom
a benign hemangioma Benign hemangioma benign hemangioma 
1.9 
Hemangiom
a benign hemangioma indeterminate indeterminate benign hemangioma 
10.5 
Hemangiom
a benign hemangioma benign hemangioma benign hemangioma 
2.5 
Hemangiom
a benign hemangioma benign hemangioma benign hemangioma 
6 
Hemangiom
a benign hemangioma benign hemangioma benign hemangioma 
3.6 metastases malignant metastases malignant metastases malignant metastases 
1.3 metastases malignant HCC malignant HCC malignant HCC 
2.6 metastases malignant metastases malignant metastases malignant metastases 
2.5 metastases malignant metastases malignant metastases malignant metastases 
2.1 metastases malignant metastases malignant metastases malignant metastases 
4.3 metastases malignant metastases malignant metastases malignant metastases 
4.5 metastases malignant metastases malignant metastases malignant metastases 
FLL, focal liver lesion; HCC, hepatocellular carcinomas; ICC, intrahepatic cholangiocarcinoma; IP, inflammatory 
pseudotumor;  RN, regenerative nodule; FNH, focal nodular hyperplasias 
 




Correct diagnosis Incorrect diagnosis 
  Indeterminate Misdiagnosis 
Entire clip 38(88.4%) 2(4.7%) 3(7.0%) 
0-1min clip 34(79.1%) 4(9.3%) 5(11.6%) 
1-4min clip 37(86.1%) 4(9.3%) 2(4.7%) 
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Table 3: Results for entire clips, 0-1min clips and 1-4min clips concerning pathological diagnosis 
 
Variable 
Correct diagnosis Incorrect diagnosis 
  Indeterminate Misdiagnosis 
entire clip 32(74.4%) 5(11.6%) 6(14.0%) 
0-1min clip 31(72.1%) 5(11.6%) 7(16.3%) 
1-4min clip 31(72.1%) 8(18.6%) 4(9.3%) 
 
Table 4: Correlation of analysis of 0-1min and 1-4min clip compared with the entire clip (P-value) 
 
Variable Benign/Malignant diagnosis Pathological diagnosis 
0-1min clip 0.243 0.808 
1-4min clip 0.747 0.808 
 
To simplify the process and reduce the CEUS 
time, 0-1min clips and 1-4min clips were divided 
from entire clips in this study. Subsequently, no 
significant differences was found between 0-1min 
or 1-4min clips versus the entire clips with 
respect to malignant or benign diagnosis and 
pathological diagnosis, which means that 0-1min 
clip and 1-4min clip can be used independently 
to reach valid diagnosis in CEUS of FLLs. 
Additionally, our study also demonstrated that it’s 
possibility of CEUS for testing two different FLLs 
based on 0-1min and 1-4min clip with only one 
injection of contrast agent. 
 
Typical haemangiomas will show peripheral 
nodular enhancement (PNE) in arterial phase of 
CEUS, whereas untypical haemangiomas would 
not observe PNE (especially seen in small 
haemangiomas), resulting in misdiagnosis by 0-
1min clips, but the gray-scale ultrasound of 
hyperecho in normal liver tissue would help to 
obtain correct diagnosis [6,9,10]. In our study, for 
the 6 haemangiomapatients, 0-1min clips 
obtained correct pathologic diagnosis in 5 
patients, and 1-4min and the entire clips obtained 
correct pathologic diagnosis in all the 6 patients. 
The CEUS characteristic of typical FNH is 
centrifugal filling with central spoke wheel-
shaped contrast enhancement during the arterial 
phase [6,9,10]. Thus the absence of central 
spoke wheel may result in wrong diagnosis within 
FNH nodules, which might be misdiagnosed as 
malignant lesions because of rapidly filling in the 
artery phase. However, it did not affect the 
diagnosis as benign nodules by the entire clips 
and 1-4min clips in our investigation. 
 
The HCC multistep carcinogenesis could lead to 
changes in intra-nodular blood supply, consisting 
in a progressive decrease of the portal supply 
associated to a decrease in normal arterial 
supply, subsequently overcome by increase of 
newly formed tumoral arterial supply [11-13]. 
Generally, regenerative nodules are nearly iso-
enhancing in all phases but the not negligible 
rate of HCCs showing this same vascular pattern 
(the so-called “hypovascular HCC” approximately 
10-20 %) [14]. The differential diagnosis among 
regenerative nodule, hepatocellular adenoma 
and HCC is not always easy to be reached, 
which imposes a strict recall strategy for any 
newly detected lesion in cirrhosis [15]. Contrast 
features of metastases at CEUS are hyper-
enhancement during the arterial phase (or rim-
like enhancement with non-enhancing central 
areas in hypo-vascular metastases) followed by 
marked hypo-enhancement during the late phase 
[16]. Metastases especially small FLL, without 
hypo-enhancement, present homogenous 
enhancement, may influence the diagnosis by 
the entire clip and 0-1min clip. But the history 
and appearance of multiply FLLs can do some 
help. Intrahepatic cholangiocarcinoma (ICC) is a 
tough diagnostic challenge duo to its 
asymptomatic clinical features and atypical 
imaging characteristics [17,18]. Commonly, it is 
more difficult to distinguish smaller ICC (diameter 
≤3 cm) from HCC on CEUS, corresponding to 
more frequently appeared homogeneous hyper-
enhancement [19]. In our study, similar with the 
entire clips, the 0-1min clips could correct 
diagnose 14 in 16 patients. In addition, for the 7 
patients with liver metastases, all the 0-1min, 1-4 
min and entire clips could correct diagnose 6 
patients.  
 
Inflammatory pseudotumor (IP) is an uncommon 
benign lesion with a variable degree of CEUS 
enhancement appearance [20]. In this study, one 
IP with absent contrast enhancement was 
diagnosed correctly, while two IPs with 
enhancement in arterial phase and hypoechoic 
appearance in late phases were misdiagnosed 
as HCC or indeterminate lesion. This 
phenomenon has been seen in another study 
[21]. The various CEUS patterns of IP were 
deemed to relate with different quantity of cellular 
areas and intense fibrosis areas [20,22]. 
Unfortunately, until now, there has been no 
systematic report on the CEUS appearance of 
IP, which needs further study. In routine clinical 
practice, a definitive and exact differential 
diagnosis of FLLs with CEUS entire clip is 
possible only in some types of lesions, whilst the 
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simple categorization of a lesion as benign or 
malignant can be achieved with extremely high 
sensitivity (>90 %) and specificity [2], as well as 
with an accuracy comparable to CT or MRI in 
most series [23-26]. Additionally, in typical 
lesions the 0-1min clip and 1-4min clip could be 
comparable to the entire clip in diagnosis of FLLs 
aforementioned. 
  
However, we could see that some lesions might 
have atypical contrast-enhancement patterns 
(ACEP), which may lead to misdiagnosis. 
Between 5 and 25 % FLLs remains 
indeterminate even after CEUS (especially in 
cirrhotic livers) [5,6,9,21,27,28]. These situations 
could go against the 0-1min clip and 1-4min clip 
derived from the entire CEUS clip much more 
seriously. Thus, the ACEP FLLs need to be 
characterized by other diagnostic investigations.  
 
Limitations of the study 
 
First, the main limitation of the study was that s 
other FLLs were not included in the study and 
some of them may be difficult to differentiate 
from each other [29,30]. Therefore, the results of 
the study are only applicable for FLLs mentioned 
above. Second, since the FLLs number in our 
study is limited, the usefulness of 0-1min clip and 
1-4min clip in diagnosing FLLs is needed further 
investigation with large cases. Third, these 
findings might be related to the fact that both 
readers were blinded to the liver etiology history, 
elevation of serum biomarkers such as alpha-
fetoprotein or CA, and other laboratory findings, 
as well as other imaging findings or clinical 
presentations. The authors believe that precise 
patient history and/or further examinations are 
mandatory to reach a correct differential 
diagnosis. In addition, the experiences of 





The findings of this study demonstrate that there 
is no significant difference between CEUS entire 
clip, 0-1min clip and 1-4 min clip in identifying 
FLLs, and based on which the diagnosis of two 
different FLLs during CEUS with only one 
injection of contrast agent can be available. The 
findings also demonstrate that the appearance of 
lesions in the arterial phase is also very 
important when distinguishing between benign 
and malignant lesions, although appearance in 
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